Group 1 - The core point of the news is that Meinian Health plans to participate in the pre-restructuring of Bangjie Co., aiming to expand its business layout and enhance its competitive edge in the health management sector [1] - Meinian Health's board approved the proposal to become an interested investor in Bangjie Co.'s restructuring, designating its wholly-owned subsidiary, Meinian Big Health, as the entity to gain control of Bangjie Co. post-restructuring [1] - The investment will be funded through the company's own and raised funds, which will not significantly impact its daily operations, financial status, or operating results [1] Group 2 - Bangjie Co. was established in 1993, originally focusing on garment manufacturing, but has since expanded into photovoltaic equipment and semiconductor device sales [2] - The company faced severe operational difficulties due to a drastic decline in product prices in the photovoltaic industry, leading to a bankruptcy restructuring application for its subsidiary in September 2024 [2] - By March 2025, Bangjie Co.'s production facility in Yangzhou announced a complete shutdown, and by July 2025, the company terminated its photovoltaic project, accumulating overdue debts totaling 967 million yuan [2] Group 3 - In July 2025, a new controlling shareholder emerged for Bangjie Co., with financial losses reported at over 88 million yuan in 2023, escalating to 672 million yuan in 2024, and further to 905 million yuan by the third quarter of 2025 [3] - The court initiated pre-restructuring for Bangjie Co. in January 2026, with a recruitment announcement for restructuring investors, requiring a 20 million yuan deposit and prioritizing investors who can enhance the company's development potential [3] - Meinian Health, established in 1991, specializes in professional health examination services, including risk assessment and health management [3]